Website and social media enquiries

For all website and social media enquiries

Suzanne Bailey (Monday - Thursday)
T: 01923 779555
E: [email protected]

Gemma Marks (Friday)
T: 01923 779555
E: gemma @cureparkinsons.org.uk

Latest

Scotland's Virtual Kiltwalk

Join Scotland’s ‘virtual’ Kiltwalk challenge from the 23 – 25 April in support of The Cure Parkinson’s Trust (CPT).
Raid Local 2021: Ventoux Local

Join us on the 16th May for Raid Local 2021: Ventoux Local. Inspired by the infamous Club des Cinglés challenge to climb Mont Ventoux using 3 different routes in one day, riders will be training, planning and mapping to cover the equivalent distance and vertical ascent of 1, 2 or all 3 of those epic routes, all in one day, all on their local roads.
Webinar - Coronavirus and Parkinson's

Rewatch - Listen to stimulating discussions around recent publications on Coronavirus and Parkinson’s.
The AZA-PD study: a clinical trial of azathioprine in Parkinson's

A research group in Cambridge - supported by The Cure Parkinson's Trust and Cambridge Centre for Parkinson-Plus - will be conducting a clinical trial to test whether suppressing the immune system can help to slow the progression of Parkinson's.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more